drugset / Trial / NCT01877642

ADASUVE-Lorazepam Drug-Drug Interaction

NCT01877642 ↗

Phase 4 Completed 22 enrolled Alexza Pharmaceuticals, Inc.
RandomizedCrossoverQuadruple-blindOther

Summary

This study will compare the safety and effects over time for giving both ADASUVE and lorazepam (intramuscular) compared to that of each agent given alone.

Timeline

Start
2013-06
Primary completion
2013-07
Completion
2013-07

Outcome

Met primary endpoint

paper There was no difference between inhaled loxapine + IM lorazepam and either agent alone on respiration or pulse oximetery PMID 27022468 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorazepam Small molecule 1 mg Intramuscular
Subject loxapine Small molecule 10 mg Inhaled

Indications

No indication recorded.